GLP-1 receptor agonists such as semaglutide and tirzepatide are FDA-regulated for chronic weight management in adults with a BMI of 30 or higher, or 27 with a weight-related condition. Las Vegas runs around the clock, and dealers, servers, performers and resort staff working overnight and rotating shifts rarely fit a daytime clinic into their week - even as the job keeps appearance and stamina front of mind. Telehealth works on their clock: a licensed Nevada physician reviews your online assessment under Nevada Revised Statutes §629.515, and compounded medication from an FDA-registered 503B pharmacy ships to your Las Vegas address. Monthly cost runs $199–$379 versus about $1,247 for brand-name Ozempic or Wegovy. Medical Director: Dr. Steven Nguyen, MD, Board-Certified Internal Medicine. Serving Las Vegas ZIP codes: 89101, 89102, 89104, 89109, 89119.
Local clinics serving Downtown East: LightFit, Testo Diet Weight Loss and Hormone Center and Slim Fit MD Wellness. Many patients compare these in-person options against licensed GLP-1 telehealth — prescribed online, shipped to the door.
Ozempic in Downtown East: local pointers and concrete answers. Ozempic has become the household name for GLP-1s, but it is first and foremost a diabetes treatment: for weight loss, Wegovy (same molecule, higher dose) is the official indication.
The goal of the evaluation is not to screen for the sake of screening, but to make sure the expected benefit outweighs the risks. Pregnancy and breastfeeding are among the situations where these treatments are not indicated.
Ozempic belongs to the 'GLP-1 agonist (brand of semaglutide, diabetes indication)' class and is given as a weekly subcutaneous injection. For a Downtown East resident, Ozempic is now largely managed remotely, home delivery included. Local landmark: LightFit (1875 Village Center Cir #100, Las Vegas, NV 89134), rated 5/5 across 364 reviews. On the cost side, expect about $950-1,100/month brand-name without insurance; compounded semaglutide alternatives about $200-500/month.
That is an off-label use. Many physicians prescribe it, but the FDA indication for weight loss is Wegovy (same active ingredient, semaglutide, at a higher dose).
Same molecule (semaglutide). Ozempic is dosed/approved for diabetes, Wegovy for chronic weight loss.
Often a BMI of 30 or higher, or 27 or higher with a weight-related comorbidity, but only the medical evaluation decides.
Medical Director: Dr. Steven Nguyen, MD, Board-Certified Internal Medicine. Licensed in Nevada. All prescriptions issued under Nevada Revised Statutes §629.515 and supervised by Nevada State Board of Medical Examiners.